After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
This NYSE-listed company operates within the Healthcare Plans industry segment, falling under the Healthcare sector. The current market capitalization of Elevance Health Inc is $116.36B. A total of 1.03 million shares were traded on the day, compared to an average of 1.04M shares.
In the most recent transaction, Kendrick Charles Morgan JR sold 2,432 shares of ELV for 500.46 per share on Mar 08 ’24. After the transaction, the EVP & President, Commercial now owns 15,840 company shares. In a previous transaction on Mar 06 ’24, Penczek Ronald W sold 916 shares at 504.58 per share. ELV shares that CAO & Controller owns now total 1,764.
Among the insiders who sold shares, Haytaian Peter D disposed of 21,095 shares on Mar 04 ’24 at a per-share price of $500.18. This resulted in the EVP & Pres Carelon & CarelonRx holding 18,887 shares of ELV after the transaction. In another insider transaction, PERU RAMIRO G sold 753 shares at $500.00 per share on Feb 07 ’24. Company shares held by the Director now total 9,109.
Dividend
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. Elevance Health Inc pays an annual dividend of $6.07, resulting in a dividend yield of 1.21%, and it has a price to earnings (P/E) ratio of 19.87. ELV’s most recent ex-dividend date was 3/7/2024 when it declared a $1.63 quarterly dividend that was paid in cash on 3/22/2024. Previously, the company paid the dividend on 12/21/2023 with an ex-dividend date of 12/5/2023. The ELV stock dividend was $1.48 per share in cash.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ELV has a high of $521.18 and a low of $412.00.
As of this writing, ELV has an earnings estimate of $e.l.f. Beauty, Inc. per share for the current quarter. EPS was calculated based on a consensus of iShares Silver Trust estimates, with a high estimate of $Estee Lauder Companies, Inc. (T per share and a lower estimate of $Elevance Health, Inc..
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ELV’s latest balance sheet shows that the firm has $31.15B in Cash & Short Term Investments as of fiscal 2021. Its Book Value Per Share was $168.64, while its Total Shareholder’s Equity was $36.13B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ELV is Buy with a score of 4.83.
